Mymee is proven to provide relief for lupus symptoms.


In the lupus clinical trial

Statistically Significant Quality of Life Improvements for Lupus Symptoms
Mymee clients who completed the study experienced clinically meaningful and statistically significant improvements in eight measurable quality of life indicators:

Pain

Pain Interference

Physical Health

Planning

Burden to others

Emotional Health

Body Image
Three validated Health-Related Quality of Life (HRQoL) tools were used in the assessment: Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F); Brief Pain Inventory-Short Form (BPI-SF), and Lupus Quality of Life (LupusQoL).
Proven Improvement with Fatigue

Fatigue, one of the most debilitating symptoms reported by people with lupus, was among the quality of life indicators that saw considerable improvement. Fatigue is highly correlated with work disability, workplace absence, and impaired workplace performance.
Proven Improvement in Pain and Pain Interference

Pain and pain interference are quality of life indicators that impact many lupus patients and seriously impair their functional capacity. With Mymee, many patients saw improvements in either or both pain and pain interference.
More on the assessment of improvement of symptoms for Mymee clients with lupus: In the clinical trial, adults with lupus were assigned to either Mymee plus usual care or to a control group who received usual care alone. Primary outcome measures were changes between baseline and 16 sessions.
Lupus Success Stories from Mymee Clients

.jpg?width=500&name=Untitled%20design%20(67).jpg)
